Re-challenging with anti-CD38 monotherapy in triple-refractory multiple myeloma patients is a feasible and safe approach

被引:19
作者
Alici, Evren [1 ,2 ,3 ]
Chrobok, Michael [1 ,3 ]
Lund, Johan [1 ,2 ]
Ahmadi, Tahamtan [4 ]
Khan, Imran [4 ]
Duru, Adil D. [1 ,3 ]
Nahi, Hareth [1 ,2 ,3 ]
机构
[1] Karolinska Inst, Karolinska Univ Hosp Huddinge, Ctr Haematol & Regenerat Med, Stockholm, Sweden
[2] Karolinska Univ Hosp Huddinge, Haematol Ctr, Stockholm, Sweden
[3] Vaccine & Gene Therapy Inst Florida, Ctr Dis Aging, Port St Lucie, FL USA
[4] Janssen Res & Dev LLC, Spring House, PA USA
关键词
CD38; daratumumab; relapsed and refractory multiple myeloma; response;
D O I
10.1111/bjh.13776
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:473 / 477
页数:5
相关论文
共 5 条
[1]   CD38/CD19: a lipid raft-dependent signaling complex in human B cells [J].
Deaglio, Silvia ;
Vaisitti, Tiziana ;
Billington, Richard ;
Bergui, Luciana ;
Omede, Paola ;
Genazzani, Armando A. ;
Malavasi, Fabio .
BLOOD, 2007, 109 (12) :5390-5398
[2]   Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study [J].
Kumar, S. K. ;
Lee, J. H. ;
Lahuerta, J. J. ;
Morgan, G. ;
Richardson, P. G. ;
Crowley, J. ;
Haessler, J. ;
Feather, J. ;
Hoering, A. ;
Moreau, P. ;
LeLeu, X. ;
Hulin, C. ;
Klein, S. K. ;
Sonneveld, P. ;
Siegel, D. ;
Blade, J. ;
Goldschmidt, H. ;
Jagannath, S. ;
Miguel, J. S. ;
Orlowski, R. ;
Palumbo, A. ;
Sezer, O. ;
Rajkumar, S. V. ;
Durie, B. G. M. .
LEUKEMIA, 2012, 26 (01) :149-157
[3]   Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma [J].
Lin, P ;
Owens, R ;
Tricot, G ;
Wilson, CS .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (04) :482-488
[4]   Daratumumab, a CD38 Monoclonal Antibody in Patients with Multiple Myeloma - Data From a Dose-Escalation Phase I/II Study [J].
Plesner, Torben ;
Lokhorst, Henk ;
Gimsing, Peter ;
Nahi, Hareth ;
Lisby, Steen ;
Richardson, Paul G. .
BLOOD, 2012, 120 (21)
[5]   Flow cytometric detection of aneuploid CD38++ plasmacells and CD19+ B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients [J].
Santonocito, AM ;
Consoli, U ;
Bagnato, S ;
Milone, G ;
Palumbo, GA ;
Di Raimondo, F ;
Stagno, F ;
Guglielmo, P ;
Giustolisi, R .
LEUKEMIA RESEARCH, 2004, 28 (05) :469-477